WAT vs ZBIO · P/E 32, rev $3.17B vs rev $10.0M
Waters Corporation (WAT) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
WAT currently screens at market cap $20.84B and trailing P/E 31.8. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the WAT and ZBIO stock pages for the full models.
Not investment advice.